This finding is consistent with the study conducted by Valérie F.E.D. Smolders et al, which also highlighted the involvement of IL-1B, CXCL8, and other factors in the progression of CTEPH [47]. This evidence concerns the gene CXCL8 and chronic thromboembolic pulmonary hypertension.